Found 57 matching trials
Ezetimibe (SCH 58235) Taken With Either Atorvastatin or Simvastatin in Participants With Familial Hypercholesterolemia (MK-0653-018) PHASE3 The primary objective of this study is to evaluate the efficacy and the saf...
Show More Location
Multiple Locations
Learn More & Join Trial
Simvastatin With or Without Ezetimibe and Atherothrombotic Biomarker Assessment PHASE4 To determine whether the combination of ezetimibe and simvastatin improves ...
Show More Location
VA Maryland Health Care System
Learn More & Join Trial
Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study) PHASE4 Peripheral arterial disease (PAD) occurs when arteries become narrowed or h...
Show More Location
Baylor College of Medicine
Learn More & Join Trial
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE) PHASE3 Primary Objective:
To provide participants with severe hypercholesterolemi...
Show More Location
Investigational Site Number 040001
Learn More & Join Trial
Study of Heart and Renal Protection PHASE4 The chief aim of SHARP was to determine whether lowering blood LDL choleste...
Show More Location
Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford
Learn More & Join Trial
Pharmacokinetic Drug Interactions of AEGR-733 on Lipid-lowering Agents PHASE2 This phase II, open-label research study was conducted in 129 healthy volun...
Show More Location
University of Pennsylvania
Learn More & Join Trial
EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089) PHASE4 In patients with coronary artery disease and a LDL-C level between 2.5 mmol...
Show More Location
Multiple Locations
Learn More & Join Trial
Effect of Ezetimibe or Simvastatin or Both on Low Densitiy Lipoprotein -Subfractions in Patients With Type 2 Diabetes PHASE4 It is of interest how ezetimibe alone or in combination with statin may inf...
Show More Location
Institut für Stoffwechselforschung
Learn More & Join Trial
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE PHASE3 The primary aim is to assess the effects of raising HDL cholesterol (the go...
Show More Location
Clinical Trial Service Unit, University of Oxford
Learn More & Join Trial
Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED) PHASE4 The purpose of this study is to determine the safety and tolerability of ez...
Show More Location
Multiple Locations
Learn More & Join Trial